Lakeside Announces Fiscal 2025 Second Quarter and Six-Month Results

PR Newswire02-14

ITASCA, Ill. , Feb. 14, 2025 /PRNewswire/ -- Lakeside Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH), a U.S.-based cross-border supply chain solution provider with a unique focus on the ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2511610462?lang=en_US&edition=full_marsco","thumbnail":"","is_english":true,"pubTime":"2025-02-15 05:30","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2511610462","market":"us","top_or_hot":-1,"title":"Lakeside Announces Fiscal 2025 Second Quarter and Six-Month Results","media":"PR Newswire","content":"<div>\n<p>ITASCA, Ill. , Feb. 14, 2025 /PRNewswire/ -- Lakeside Holding Limited (\"Lakeside\" or the \"Company\") (Nasdaq: LSH), a U.S.-based cross-border supply chain solution provider with a unique focus on the ...</p>\n\n<a href=\"https://finance.yahoo.com/news/lakeside-announces-fiscal-2025-second-213000662.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Lakeside Announces Fiscal 2025 Second Quarter and Six-Month Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLakeside Announces Fiscal 2025 Second Quarter and Six-Month Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-02-15 05:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/lakeside-announces-fiscal-2025-second-213000662.html><strong>PR Newswire</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>ITASCA, Ill. , Feb. 14, 2025 /PRNewswire/ -- Lakeside Holding Limited (\"Lakeside\" or the \"Company\") (Nasdaq: LSH), a U.S.-based cross-border supply chain solution provider with a unique focus on the ...</p>\n\n<a href=\"https://finance.yahoo.com/news/lakeside-announces-fiscal-2025-second-213000662.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4021","symbol_name":"海运","start_time":0,"source_url":"https://finance.yahoo.com/news/lakeside-announces-fiscal-2025-second-213000662.html","article_id":"2511610462","we_media_id":null,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/lakeside-announces-fiscal-2025-second-213000662.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2511610462","pubTimestamp":1739568600,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"ITASCA, Ill., Feb. 14, 2025 /PRNewswire/ --Lakeside Holding Limited  , a U.S.-based cross-border supply chain solution provider with a unique focus on the Asia-Pacific market operating through two specialized subsidiaries—American Bear Logistics and Hupan Pharmaceutical  Co., Ltd., today announced financial results for its fiscal 2025 second quarter and first half ended December 31, 2024.Henry Liu, Chairman and Chief Executive Officer of Lakeside commented, \"While we faced industry-wide headwinds in the second quarter, we've made tremendous strategic progress in positioning Lakeside for long-term growth. Our expansion into pharmaceutical logistics through Hupan Pharmaceutical, our new partnerships with major e-commerce platforms, and our significantly-expanded Dallas-Fort Worth facilities demonstrate our commitment to diversifying and strengthening our business. The strong growth in our Asia-based customer revenues, up 29.4% in the first half, validates our strategic shift toward servi","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4021":"海运","LSH":"Lakeside Holding Limited"},"translate_title":"Lakeside公布2025财年第二季度和六个月业绩","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LSH":0.9},"content_text":"ITASCA, Ill. , Feb. 14, 2025 /PRNewswire/ -- Lakeside Holding Limited (\"Lakeside\" or the \"Company\") (Nasdaq: LSH), a U.S.-based cross-border supply chain solution provider with a unique focus on the Asia-Pacific market operating through two specialized subsidiaries—American Bear Logistics and Hupan Pharmaceutical (Hubei) Co., Ltd., today announced financial results for its fiscal 2025 second quarter and first half ended December 31, 2024.\nManagement Commentary\nHenry Liu, Chairman and Chief Executive Officer of Lakeside commented, \"While we faced industry-wide headwinds in the second quarter, we've made tremendous strategic progress in positioning Lakeside for long-term growth. Our expansion into pharmaceutical logistics through Hupan Pharmaceutical, our new partnerships with major e-commerce platforms, and our significantly-expanded Dallas-Fort Worth facilities demonstrate our commitment to diversifying and strengthening our business. The strong growth in our Asia-based customer revenues, up 29.4% in the first half, validates our strategic shift toward serving the rapidly expanding cross-border e-commerce market. With these foundational pieces in place and our continued investment in operational capabilities, we're excited about the opportunities ahead as we build a more robust, diversified logistics enterprise.\"\nOperational Highlights\nE-Commerce & Cross-Border Logistics:\n\nEntered one-year agreement with a major Asian e-commerce platform\nPartnered with a leading global social media and e-commerce platform for customs brokerage services\nLaunched new Pick & Pack Fulfillment service for a major Chinese logistics partner\n\nU.S. Facilities Expansion:\n\nExpanded Dallas-Fort Worth operations:\n   \nMore than doubled warehouse space from 20,000 to 46,657 square feet\nAdded staff to support expanded operations\nPart of multi-hub strategy including Chicago O'Hare (ORD), Dallas-Fort Worth (DFW), and Los Angeles (LAX)\n\n\nMedical/Pharmaceutical Business Development:\n\nAcquired Hupan Pharmaceutical (Hubei) Co., Ltd:\n   \nPurchase price: RMB 4.0M ($0.6M)\nExpected annual revenue contribution: $7M\nGained licenses for drug wholesale, retail, and medical device distribution\nPartnerships with 15 major Wuhan hospitals\n\nEstablished partnership with Sinopharm Group Hubei Co., Ltd. for:\n   \nEssential medicine storage\nTransportation services\nLogistics services\n\nSigned RMB 11.0M ($1.5M) sales agreement with Sinopharm Holding Hubei New Special Medicine Co., Ltd:\n   \nOne-year contract effective January 1, 2025\nCovers critical medicines including Sodium Bicarbonate, Glucose, and Glucose Sodium Chloride\n\n\nFinancial Results for the Three Months Ending December 31, 2024:\nTotal revenues decreased by $1.5 million, or 31.3% to $3.4 million for the three months ended December 31, 2024, compared with $4.9 million for the three months ended December 31, 2023. The decrease was primarily driven by a significant decline in volume we handled from our cross-border airfreight solutions.\n\nRevenues from our cross-border airfreight solutions decreased by $1.1 million or 35.5%, from $3.1 million in the three months ended December 31, 2023, to $2.0 million in the three months ended December 31, 2024. The decrease was primarily due to a decrease in the volume of cross-border air freight processed, from approximately 8,217 tons for the three months ended December 31, 2023, to approximately 4,459 tons for the three months ended December 31, 2024.\nRevenues from our cross-border ocean freight solutions decreased by $0.4 million, or 24.2%, from $1.8 million in the three months ended December 31, 2023, to $1.4 million in the three months ended December 31, 2024. This reduction was primarily due to a decrease in the volume of cross-border ocean freights processed and forwarded, dropping from 1,330 TEU in the three months ended December 31, 2023, to 1,046 TEU in the three months ended December 31, 2024.\nFor the three months ended December 31, 2024, our total revenue from pharmaceutical product distribution amounted to $0.2 million, compared to no revenue from this segment in the same period of the prior year. Starting from December 2024, we established a new revenue stream through the distribution of pharmaceutical products. We procured pharmaceuticals—primarily pharmaceutical solutions—directly from manufacturers and supplied them to distributors, hospitals, and clinics.\n\nRevenues by Customer Geographic\n\n\n\n\n\n\nFor the three months ended December 31, \n\n\n\n\n\n\n\n\n\n\n\n2024 \n\n\n2023 \n\n\n\n\n\n\n\n\n\nRevenues \n\nAmount \n\n\n% of total Revenues \n\n\nAmount \n\n\n% of total Revenues \n\n\nAmount Increase (Decrease) \n\n\nPercentage Increase (Decrease) \n\n\n\nRevenue from cross-border freight solutions \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nAsia-based customers \n\n$ \n2,750,202 \n\n\n\n76.5 \n% \n\n$ \n2,602,745 \n\n\n\n52.9 \n% \n\n$ \n147,457 \n\n\n\n5.7 \n% \n\n\nU.S.-based customers \n\n\n627,301 \n\n\n\n17.4 \n% \n\n\n2,313,358 \n\n\n\n47.1 \n% \n\n\n(1,686,057) \n\n\n\n(72.9) \n% \n\n\n\n\n\n3,377,503 \n\n\n\n93.9 \n% \n\n\n4,916,103 \n\n\n\n100.0 \n% \n\n\n(1,538,600) \n\n\n\n(31.3) \n% \n\n\nRevenue from distribution of pharmaceuticals \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nAsia-based customers \n\n\n218,086 \n\n\n\n6.1 \n% \n\n\n- \n\n\n\n- \n\n\n\n218,086 \n\n\n\nN/A \n\n\n\nTotal revenues \n\n$ \n3,595,587 \n\n\n\n100.0 \n% \n\n$ \n4,916,103 \n\n\n\n100.0 \n% \n\n$ \n(1,320,514) \n\n\n\n(26.9) \n% \n\n\n\n\n\nRevenues from Asia-based customers increased by $0.1 million, or 5.7%, from $2.6 million in the three months ended December 31, 2023, to $2.8 million in the three months ended December 31, 2024. The increase in revenues from Asia-based customers was driven by a surge in volume from these customers, particularly those serving large e-commerce platforms. This growth reflects the rising demand for our services, a direct result of the overall expansion of the U.S. e-commerce market.\nRevenues from U.S.-based customers decreased by $1.7 million, or 72.9%, from $2.3 million in the three months ended December 31, 2023 to $0.6 million in the same period in 2024. The decrease in revenue from the U.S.-based customers in the three months ended December 31, 2024, compared to the same period in 2023, was primarily due to our strategic shift toward Asia-based e-commerce customers.\n\nTotal cost of revenues decreased by $0.2 million, or 5.6%, from $3.9 million in the three months ended December 31, 2023, to $3.6 million in the three months ended December 31, 2024.\nOur overall gross loss was $42,231 in the three months ended December 31, 2024, compared to gross profit of $1,064,509 in same period last year . Our gross margin was mainly impacted by higher cost of revenue, particular in fixed overhead costs, and an industry-wide decline in revenue.\nOur gross margin of distribution of pharmaceuticals was 44.2% for the three months ended December 31, 2024.\nGeneral and administrative expenses increased by $0.9 million, or 94.1%, from $1.0 million in the three months ended December 31, 2023, to $1.9 million in the three months ended December 31, 2024. These expenses represented 53.2% and 20.0% of our total revenues for the three months ended December 31, 2024 and 2023, respectively. The increase was primarily attributed to higher salary and employee benefit expenses and professional fees operating as a listed company.\nNet loss was $1.9 million for the three months ended December 31, 2024, compared to a net income of $0.06 million for the three months ended December 31, 2023.\nFinancial Results for the Six Months Ending December 31, 2024:\nTotal revenues decreased by $1.6 million, or 17.7%, from $9.1 million for the six months ended December 31, 2023, to $7.5 million for the six months ended December 31, 2024. The decrease was primarily driven by a significant decline in volume we handled from our cross-border airfreight solutions.\n\nRevenues from our cross-border airfreight solutions decreased by $1.3 million or 23.4%, from $5.5 million in the six months ended December 31, 2023, to $4.2 million in the six months ended December 31, 2024. The decrease was primarily due to a decrease in the volume of cross-border air freight processed, from approximately 16,034 tons for the six months ended December 31, 2023, to approximately 11,732 tons for the six months ended December 31, 2024.\nRevenues from our cross-border ocean freight solutions decreased by $0.3 million, or 8.7%, from $3.5 million in the six months ended December 31, 2023, to $3.2 million in the six months ended December 31, 2024. This growth was primarily due to a decrease in the volume of cross-border ocean freights processed and forwarded, dropping from 2,620 TEU in the six months ended December 31, 2023, to 2,476 TEU in the six months ended December 31, 2024.\n\nRevenues by Customer Geographic\n\n\n\n\n\n\nFor the six months ended December 31, \n\n\n\n\n\n\n\n\n\n\n\n2024 \n\n\n2023 \n\n\n\n\n\n\n\n\n\nRevenues \n\nAmount \n\n\n% of total Revenues \n\n\nAmount \n\n\n% of total Revenues \n\n\nAmount Increase (Decrease) \n\n\nPercentage Increase (Decrease) \n\n\n\nRevenue from cross-border freight solutions \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nAsia-based customers \n\n$ \n5,559,837 \n\n\n\n72.4 \n% \n\n$ \n4,296,968 \n\n\n\n47.4 \n% \n\n$ \n1,262,869 \n\n\n\n29.4 \n% \n\n\nU.S.-based customers \n\n\n1,899,220 \n\n\n\n24.7 \n% \n\n\n4,767,611 \n\n\n\n52.6 \n% \n\n\n(2,868,391) \n\n\n\n(60.2) \n% \n\n\n\n\n\n7,459,057 \n\n\n\n97.2 \n% \n\n\n9,064,579 \n\n\n\n100.0 \n% \n\n\n(1,605,522) \n\n\n\n(17.7) \n% \n\n\nRevenue from distribution of pharmaceuticals \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nAsia-based customers \n\n\n218,086 \n\n\n\n2.8 \n% \n\n\n- \n\n\n\n- \n\n\n\n218,086 \n\n\n\nN/A \n\n\n\nTotal revenues \n\n$ \n7,677,143 \n\n\n\n100.0 \n% \n\n$ \n9,064,579 \n\n\n\n100.0 \n% \n\n$ \n(1,387,436) \n\n\n\n(15.3) \n% \n\n\n\n\n\nRevenues from Asia-based customers increased by $1.3 million, or 29.4%, from $4.3 million in the six months ended December 31, 2023, to $5.6 million in the six months ended December 31, 2024. The increase in revenues from Asia-based customers was driven by an increase in volume from these customers, particularly those serving large e-commerce platforms. This growth reflects the rising demand for our services, a direct result of the overall expansion of the U.S. e-commerce market.\nRevenues from cross-border freight solutions for the U.S.-based customers decreased by $2.9 million, or 60.2%, from $4.8 million in the six months ended December 31, 2023 to $1.9 million in the same period in 2024. The decrease in revenue from the U.S.-based customers in the three months ended December 31, 2024, compared to the same period in 2023, was primarily due to our strategic shift toward Asia-based e-commerce customers.\n\nCost of revenues decreased by $0.2 million, or 2.1%, from $7.4 million in the six months ended December 31, 2023, to $7.2 million in the six months ended December 31, 2024.\nGross profit decreased by $1.2 million, or 71.9%, from $1.7 million in the six months ended December 31, 2023, to $0.5 million in the six months ended December 31, 2024. Our gross margin of cross-border freight solution was 5.1% for the six months ended December 31, 2024, compared to 18.9% for the six months ended December 31, 2023. The decline in gross margin was primarily attributable to reduced revenue from cross-border airfreight solutions and an increase in our cost of revenue in warehouse services, custom declaration and terminal charges, freights arranged charges and overhead costs allocated.\nGeneral and administrative expenses increased by $1.9 million, or 103.7%, from $1.8 million in the six months ended December 31, 2023, to $3.7 million in the six months ended December 31, 2024. These expenses represented 48.8% and 20.3% of our total revenues for the six months ended December 31, 2024 and 2023, respectively. The increase was primarily attributed to higher salary and employee benefit expenses, professional fees, office expenses and traveling, insurance expenses and entertainment expenses, operating as a listed company.\nNet loss was $3.3 million for the six months ended December 31, 2024, compared to a net loss of $0.2 million for the six months ended December 31, 2023.\nConference Call & Audio Webcast\nLakeside's management team will hold an earnings conference call at 4:30 PM Eastern Time (3:30 PM Central Time) on Tuesday, February 17 to discuss the Company's financial results and provide an overview of the Company's operations. Management will lead the conference call and be available to answer questions.\nTo access the call by phone, please dial 1- 877-407-9716 (international callers, please dial 1- 201-493-6779) approximately 10 minutes before the start of the call. Refer to conference ID: LAKESIDE. **NOTE: THIS CONFERENCE ID WILL BE REQUIRED FOR ENTRY\nA live audio conference call webcast will be available online athttps://viavid.webcasts.com/starthere.jsp?ei=1708554&tp_key=b4f1b10725\nAbout Lakeside Holding Limited\nLakeside Holding Limited is a U.S.-based cross-border supply chain solution provider with a unique focus on the Asia-Pacific market. Through two specialized subsidiaries—American Bear Logistics and Hupan Pharmaceutical (Hubei) Co., Ltd.—Lakeside delivers tailored logistics solutions spanning general and specialized sectors.\nAmerican Bear Logistics, with strategic hubs in Chicago, Dallas, Los Angeles, and New York, offers customized cross-border ocean and airfreight solutions, connecting Asia-based logistics service companies and e-commerce platforms with the U.S. market.\nLakeside recently acquired Hupan Pharmaceutical (Hubei) Co., Ltd., expanding its service scope and enhancing its pharmaceutical logistics and distribution capabilities within China. This strategic move underscores Lakeside's commitment to advancing integrated cross-border logistics solutions.\nFor more information, please visit https://lakeside-holding.com.\nSafe Harbor Statement\nThis press release contains forward-looking statements that reflect our current expectations and views of future events. Known and unknown risks, uncertainties and other factors may cause our actual results, performance or achievements to be materially different from those expressed or implied by the forward-looking statements. You can identify some of these forward-looking statements by words or phrases such as \"may,\" \"will,\" \"expect,\" \"anticipate,\" \"aim,\" \"estimate,\" \"intend,\" \"plan,\" \"believe,\" \"is/are likely to,\" \"potential,\" \"continue\" or other similar expressions. We have based these forward-looking statements largely on our current expectations and projections about future events that we believe may affect our financial condition, results of operations, business strategy and financial needs. These forward-looking statements involve various risks and uncertainties. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. We qualify all of our forward-looking statements by these cautionary statements.\nInvestor Relations Contact:\nMatthew Abenante, IRCPresidentStrategic Investor Relations, LLCTel: 347-947-2093Email: matthew@strategic-ir.com\n(tables follow)\n\n\n\n\nLAKESIDE HOLDING LIMITED \n\n\nCONDENSED CONSOLIDATED BALANCE SHEETS \n\n\n(UNAUDITED) \n\n\n\n\n\n\n\nAs ofDecember 31,2024 (unaudited) \n\n\nAs ofJune 30,2024 (audited) \n\n\n\nASSETS \n\n\n\n\n\n\n\n\nCURRENT ASSETS \n\n\n\n\n\n\n\n\nCash \n\n$ \n1,123,414 \n\n\n$ \n123,550 \n\n\n\nAccounts receivable – third parties, net \n\n\n1,645,774 \n\n\n\n2,082,152 \n\n\n\nAccounts receivable – related party, net \n\n\n207,293 \n\n\n\n763,285 \n\n\n\nPrepayment and other receivable \n\n\n49,476 \n\n\n\n— \n\n\n\nContract assets \n\n\n31,388 \n\n\n\n129,506 \n\n\n\nInventory, net \n\n\n10,328 \n\n\n\n— \n\n\n\nDue from related parties \n\n\n682,980 \n\n\n\n441,279 \n\n\n\nLoan to a third party \n\n\n686,697 \n\n\n\n— \n\n\n\nTotal current assets \n\n\n4,437,350 \n\n\n\n3,539,772 \n\n\n\n\n\n\n\n\n\n\n\n\n\n\nNON-CURRENT ASSETS \n\n\n\n\n\n\n\n\n\n\nInvestment in other entity \n\n\n15,741 \n\n\n\n15,741 \n\n\n\nProperty and equipment at cost, net of accumulated depreciation \n\n\n514,073 \n\n\n\n344,883 \n\n\n\nIntangible asset, net \n\n\n418,867 \n\n\n\n— \n\n\n\nRight of use operating lease assets \n\n\n4,074,617 \n\n\n\n3,471,172 \n\n\n\nRight of use financing lease assets \n\n\n110,998 \n\n\n\n37,476 \n\n\n\nDeferred tax asset \n\n\n— \n\n\n\n89,581 \n\n\n\nDeferred offering costs \n\n\n— \n\n\n\n1,492,798 \n\n\n\nDeposit and prepayment \n\n\n265,480 \n\n\n\n202,336 \n\n\n\nTotal non-current assets \n\n\n5,399,776 \n\n\n\n5,653,987 \n\n\n\nTOTAL ASSETS \n\n$ \n9,837,126 \n\n\n$ \n9,193,759 \n\n\n\n\n\n\n\n\n\n\n\n\n\n\nLIABILITIES AND EQUITY \n\n\n\n\n\n\n\n\n\n\nCURRENT LIABILITIES \n\n\n\n\n\n\n\n\n\n\nAccounts payables – third parties \n\n$ \n1,233,142 \n\n\n$ \n1,161,858 \n\n\n\nAccounts payables – related parties \n\n\n71,557 \n\n\n\n227,722 \n\n\n\nAccrued liabilities and other payables \n\n\n1,244,501 \n\n\n\n1,335,804 \n\n\n\nCurrent portion of obligations under operating leases                                                                    \n\n\n2,203,766 \n\n\n\n1,186,809 \n\n\n\nCurrent portion of obligations under financing leases \n\n\n48,865 \n\n\n\n37,619 \n\n\n\nLoans payable, current \n\n\n609,935 \n\n\n\n746,962 \n\n\n\nDividend payable \n\n\n— \n\n\n\n98,850 \n\n\n\nTax payable \n\n\n79,825 \n\n\n\n79,825 \n\n\n\nDue to shareholders \n\n\n— \n\n\n\n1,018,281 \n\n\n\nTotal current liabilities \n\n\n5,491,591 \n\n\n\n5,893,730 \n\n\n\n\n\n\n\n\n\n\n\n\n\n\nNON-CURRENT LIABILITIES \n\n\n\n\n\n\n\n\n\n\nLoans payable, non-current \n\n\n174,846 \n\n\n\n136,375 \n\n\n\nDeferred tax liabilities \n\n\n104,717 \n\n\n\n— \n\n\n\nObligations under operating leases, non-current \n\n\n2,339,439 \n\n\n\n2,506,402 \n\n\n\nObligations under financing leases, non-current \n\n\n80,252 \n\n\n\n17,460 \n\n\n\nTotal non-current liabilities \n\n\n2,699,254 \n\n\n\n2,660,237 \n\n\n\nTOTAL LIABILITIES \n\n$ \n8,190,845 \n\n\n$ \n8,553,967 \n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCommitments and Contingencies \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nEQUITY \n\n\n\n\n\n\n\n\n\n\nCommon stocks, $0.0001 par value, 200,000,000 shares authorized,7,500,000 and 6,000,000 issued and outstanding as of December 31, 2024 and June 30, 2024, respectively \n\n\n750 \n\n\n\n600 \n\n\n\nSubscription receivable \n\n\n— \n\n\n\n(600) \n\n\n\nAdditional paid-in capital \n\n\n4,942,791 \n\n\n\n642,639 \n\n\n\nAccumulated other comprehensive income \n\n\n(9,214) \n\n\n\n2,972 \n\n\n\nDeficits \n\n\n(3,288,046) \n\n\n\n(5,819) \n\n\n\nTotal equity \n\n\n1,646,281 \n\n\n\n639,792 \n\n\n\n\n\n\n\n\n\n\n\n\n\n\nTOTAL LIABILITIES AND EQUITY \n\n$ \n9,837,126 \n\n\n$ \n9,193,759 \n\n\n\n\n\n\n\n\n\nLAKESIDE HOLDING LIMITED \n\n\nCONDENSED CONSOLIDATED STATEMENT OF INCOME (LOSS) AND COMPREHENSIVE INCOME (LOSS) \n\n\n(UNAUDITED) \n\n\n\n\n\n\n\nSix Months Ended December 31, \n\n\nThree Months Ended December 31, \n\n\n\n\n\n2024 \n\n\n2023 \n\n\n2024 \n\n\n2023 \n\n\n\nRevenue from cross-border freight solutions – third party \n\n$ \n6,702,063 \n\n\n$ \n8,639,983 \n\n\n$ \n3,102,276 \n\n\n$ \n4,585,696 \n\n\n\nRevenue from cross-border freight solutions – related parties \n\n\n756,994 \n\n\n\n424,596 \n\n\n\n275,227 \n\n\n\n330,407 \n\n\n\nRevenue from distribution of pharmaceutical products – third parties \n\n\n218,086 \n\n\n\n— \n\n\n\n218,086 \n\n\n\n— \n\n\n\nTotal revenue \n\n\n7,677,143 \n\n\n\n9,064,579 \n\n\n\n3,595,589 \n\n\n\n4,916,103 \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCost of revenue from cross-border freight solutions – third party \n\n\n6,153,994 \n\n\n\n6,329,650 \n\n\n\n3,159,709 \n\n\n\n3,424,053 \n\n\n\nCost of revenue from cross-border freight solutions – related party \n\n\n921,050 \n\n\n\n1,022,877 \n\n\n\n356,320 \n\n\n\n427,541 \n\n\n\nCost of revenue from pharmaceuticalproducts – related parties \n\n\n121,791 \n\n\n\n— \n\n\n\n121,791 \n\n\n\n— \n\n\n\nTotal cost of revenue \n\n\n7,196,835 \n\n\n\n7,352,527 \n\n\n\n3,637,820 \n\n\n\n3,851,594 \n\n\n\nGross profit (loss) \n\n\n480,308 \n\n\n\n1,712,052 \n\n\n\n(42,231) \n\n\n\n1,064,509 \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nOperating expenses: \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nSelling expenses \n\n\n54,488 \n\n\n\n— \n\n\n\n54,488 \n\n\n\n— \n\n\n\nGeneral and administrative expenses \n\n\n3,749,059 \n\n\n\n1,840,831 \n\n\n\n1,911,853 \n\n\n\n985,053 \n\n\n\nLoss from deconsolidation of a subsidiary \n\n\n— \n\n\n\n73,151 \n\n\n\n— \n\n\n\n— \n\n\n\nProvision (reversal) of allowance for expectedcredit loss \n\n\n1,956 \n\n\n\n49,591 \n\n\n\n(10,881) \n\n\n\n(2,531) \n\n\n\nTotal operating expenses \n\n\n3,805,503 \n\n\n\n1,963,573 \n\n\n\n1,955,460 \n\n\n\n982,522 \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nIncome (loss) from operations \n\n\n(3,325,195) \n\n\n\n(251,521) \n\n\n\n(1,997,691) \n\n\n\n81,987 \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nOther income \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nOther income, net \n\n\n201,541 \n\n\n\n88,449 \n\n\n\n91,753 \n\n\n\n41,500 \n\n\n\nInterest expense \n\n\n(68,992) \n\n\n\n(53,864) \n\n\n\n(40,882) \n\n\n\n(31,079) \n\n\n\nTotal other income \n\n\n132,549 \n\n\n\n34,585 \n\n\n\n50,871 \n\n\n\n10,421 \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n(Loss) income before income taxes \n\n\n(3,192,646) \n\n\n\n(216,936) \n\n\n\n(1,946,820) \n\n\n\n92,408 \n\n\n\nIncome tax expense (credit) \n\n\n89,581 \n\n\n\n26,125 \n\n\n\n— \n\n\n\n28,184 \n\n\n\nNet (loss) income \n\n\n(3,282,227) \n\n\n\n(243,061) \n\n\n\n(1,946,820) \n\n\n\n64,224 \n\n\n\nLess: net loss attributable to non-controlling interest \n\n\n— \n\n\n\n(3,025) \n\n\n\n— \n\n\n\n— \n\n\n\nNet (loss) income attributable to the Company \n\n\n(3,282,227) \n\n\n\n(240,036) \n\n\n\n(1,946,820) \n\n\n\n64,224 \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nOther comprehensive (loss) income: \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nForeign currency translation income \n\n\n(12,186) \n\n\n\n3,122 \n\n\n\n(25,179) \n\n\n\n— \n\n\n\nComprehensive (loss) income \n\n\n(3,294,413) \n\n\n\n(239,939) \n\n\n\n(1,971,999) \n\n\n\n64,224 \n\n\n\nLess: comprehensive loss attributable tonon-controlling interest \n\n\n— \n\n\n\n(3,119) \n\n\n\n— \n\n\n\n— \n\n\n\nComprehensive (loss) income attributableto the Company \n\n$ \n(3,294,413) \n\n\n$ \n(236,820) \n\n\n$ \n(1,971,999) \n\n\n$ \n64,224 \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n(Loss) earnings per share – basic and diluted \n\n$ \n(0.44) \n\n\n$ \n(0.04) \n\n\n$ \n(0.26) \n\n\n$ \n0.01 \n\n\n\nWeighted Average Shares Outstanding – basic and diluted \n\n\n7,500,000 \n\n\n\n6,000,000 \n\n\n\n7,500,000 \n\n\n\n6,000,000 \n\n\n\n\n\n\n\n\n\nLAKESIDE HOLDING LIMITED \n\n\nCONDENSSED CONSOLIDATED STATEMENTS OF CASH FLOWS \n\n\n(UNAUDITED) \n\n\n\n\n\n\n\nFor the Six Months Ended December 31, \n\n\n\n\n\n2024 \n\n\n2023 \n\n\n\nCash flows from operating activities: \n\n\n\n\n\n\n\n\nNet loss \n\n$ \n(3,282,227) \n\n\n$ \n(243,061) \n\n\n\nAdjustments to reconcile net loss to net cash provided byoperating activities: \n\n\n\n\n\n\n\n\n\n\nDepreciation – G&A \n\n\n50,804 \n\n\n\n35,991 \n\n\n\nDepreciation – cost of revenue \n\n\n36,328 \n\n\n\n36,328 \n\n\n\nAmortization and interest expense of operating lease assets                                                           \n\n\n989,003 \n\n\n\n439,142 \n\n\n\nDepreciation of right-of-use finance assets \n\n\n15,480 \n\n\n\n14,385 \n\n\n\nProvision of allowance for expected credit loss \n\n\n1,956 \n\n\n\n49,591 \n\n\n\nDeferred tax expense \n\n\n89,581 \n\n\n\n26,125 \n\n\n\nLoss from derecognition of shares in subsidiary \n\n\n— \n\n\n\n73,151 \n\n\n\nChanges in operating assets and liabilities: \n\n\n\n\n\n\n\n\n\n\nAccounts receivable – third parties \n\n\n424,648 \n\n\n\n(479,056) \n\n\n\nAccounts receivable – related parties \n\n\n565,766 \n\n\n\n(192,609) \n\n\n\nContract assets \n\n\n98,118 \n\n\n\n(27,169) \n\n\n\nInventories, net \n\n\n(10,328) \n\n\n\n— \n\n\n\nDue from related parties \n\n\n(241,702) \n\n\n\n40,740 \n\n\n\nPrepayment, other deposit \n\n\n(112,620) \n\n\n\n(23,269) \n\n\n\nAccounts payables – third parties \n\n\n28,285 \n\n\n\n539,542 \n\n\n\nAccounts payables – related parties \n\n\n(156,165) \n\n\n\n241,721 \n\n\n\nAccrued expense and other payables \n\n\n312,722 \n\n\n\n122,547 \n\n\n\nOperating lease liabilities \n\n\n(742,649) \n\n\n\n(396,263) \n\n\n\nNet cash (used in) provided by operating activities \n\n\n(1,933,000) \n\n\n\n257,836 \n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCash flows from investing activities: \n\n\n\n\n\n\n\n\n\n\nPurchase of furniture and equipment \n\n\n(36,072) \n\n\n\n— \n\n\n\nPayment for leasehold improvement \n\n\n(75,008) \n\n\n\n— \n\n\n\nNet cash payment for asset acquisition \n\n\n(552,721) \n\n\n\n— \n\n\n\nLoan to a third party \n\n\n(686,697) \n\n\n\n— \n\n\n\nPayment made for investment in other entity \n\n\n— \n\n\n\n(29,906) \n\n\n\nNet cash outflow from deconsolidation of a subsidiary (Appendix A) \n\n\n— \n\n\n\n(48,893) \n\n\n\nNet cash used in investing activities \n\n\n(1,350,498) \n\n\n\n(78,799) \n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCash flows from financing activities: \n\n\n\n\n\n\n\n\n\n\nProceeds from loans \n\n\n195,000 \n\n\n\n225,000 \n\n\n\nRepayment of loans \n\n\n(339,914) \n\n\n\n(185,856) \n\n\n\nRepayment of equipment and vehicle loans \n\n\n(55,877) \n\n\n\n(59,708) \n\n\n\nPrincipal payment of finance lease liabilities \n\n\n(14,964) \n\n\n\n(13,429) \n\n\n\nPayment for deferring offering cost \n\n\n— \n\n\n\n(140,000) \n\n\n\nAdvances from Hupan Pharmaceutical prior to acquisition \n\n\n276,365 \n\n\n\n— \n\n\n\nProceeds from initial public offering, net of share issuancecosts \n\n\n5,351,281 \n\n\n\n— \n\n\n\nAdvanced to related parties \n\n\n(311,185) \n\n\n\n— \n\n\n\nProceeds from shareholders \n\n\n— \n\n\n\n158,455 \n\n\n\nRepayment to shareholders \n\n\n(805,345) \n\n\n\n— \n\n\n\nNet cash provided by (used in) financing activities \n\n\n4,295,361 \n\n\n\n(15,538) \n\n\n\n\n\n\n\n\n\n\n\n\n\n\nEffect of exchange rate changes on cash \n\n\n(11,999) \n\n\n\n3,216 \n\n\n\nNet increase in cash \n\n\n999,864 \n\n\n\n166,715 \n\n\n\nCash, beginning of the period \n\n\n123,550 \n\n\n\n174,018 \n\n\n\nCash, end of the period \n\n$ \n1,123,414 \n\n\n$ \n340,733 \n\n\n\n\n\n\n\n\n\n\n\n\n\n\nSUPPLEMENTAL DISCLOSURES OF CASH FLOWINFORMATION: \n\n\n\n\n\n\n\n\n\n\nCash paid for income tax \n\n$ \n— \n\n\n$ \n— \n\n\n\nCash paid for interest \n\n$ \n45,953 \n\n\n$ \n15,503 \n\n\n\n\n\n\n\n\n\n\n\n\n\n\nSUPPLEMENTAL SCHEDULE OF NON-CASH ININVESTING AND FINANCING ACTIVITIES \n\n\n\n\n\n\n\n\n\n\nDeferred offering costs within due to shareholders \n\n$ \n— \n\n\n$ \n500,826 \n\n\n\nDeferred offering costs within accrued expense and otherpayables \n\n$ \n— \n\n\n$ \n241,176 \n\n\n\nAdditions to property and equipment included in loanpayable \n\n$ \n102,235 \n\n\n\n— \n\n\n\nAdditions to leasehold improvement and furniture andfixture through account payable \n\n$ \n42,803 \n\n\n$ \n— \n\n\n\nSettlement of due to shareholder and advance to relatedparty \n\n$ \n311,815 \n\n\n\n— \n\n\n\n\n\n\n\n\n\n\n\n\n\n\nNON-CASH ACTIVITIES \n\n\n\n\n\n\n\n\n\n\nRight of use assets obtained in exchange for operating leaseobligations \n\n$ \n1,445,498 \n\n\n$ \n— \n\n\n\nRight of use assets obtained in exchange for finance leaseobligation \n\n$ \n89,003 \n\n\n$ \n19,982 \n\n\n\n\n\n\n\n\n\n\n\n\n\n\nAPPENDIX A – Net cash outflow from deconsolidation ofa subsidiary \n\n\n\n\n\n\n\n\n\n\nWorking capital, net \n\n\n\n\n\n$ \n29,812 \n\n\n\nInvestment in other entity recognized \n\n\n\n\n\n\n(15,741) \n\n\n\nElimination of NCl at deconsolidation of a subsidiary \n\n\n\n\n\n\n10,187 \n\n\n\nLoss from deconsolidation of a subsidiary \n\n\n\n\n\n\n(73,151) \n\n\n\nCash \n\n\n\n\n\n$ \n(48,893) \n\n\n\n\n\n View original content:https://www.prnewswire.com/news-releases/lakeside-announces-fiscal-2025-second-quarter-and-six-month-results-302377335.html\nSOURCE Lakeside Holding Limited","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2511610462"}